View Exam | PowerPak

1. Which of the following groups of patients experiences the greatest clinical benefit from treatment with prasugrel?

A. Patients with diabetes B. Patients who present with NSTEMI C. Patients with a history of TIA D. Patients with renal impairment

2. Which of the following medications is/are indicated for use in medically managed patients with ACS?

A. Clopidogrel B. Prasugrel C. Ticagrelor D. A and B E. A and C

3. Patients with a prior history of stroke or TIA should not receive which of the following medications?

A. Clopidogrel B. Prasugrel C. Ticagrelor D. A and B

4. Which of the following medications is recommended to be used only with aspirin doses of 75-100 mg daily?

A. Clopidogrel B. Prasugrel C. Ticagrelor D. Eptifibatide

5. Which of the following statements regarding GP IIb/IIIa inhibitors is true?

A. The use of a GP IIb/IIIa inhibitor prior to angiography is not superior to the provisional use of a GP IIb/IIIa inhibitor after angiography. B. Patients with diabetes received less benefit from a GP IIb/IIIa inhibitor than those without diabetes. C. The use of a GP IIb/IIIa inhibitor prior to angiography results in less bleeding compared with the use of a GP IIb/IIIa inhibitor after angiography. D. The use of a GP IIb/IIIa inhibitor is not recommended for patients undergoing PCI.

6. The recommended optimal duration of dual anti-platelet therapy for a patient with a bare metal stent placed following non-ST elevation MI is:

A. 2 weeks B. 4 weeks C. 6 months D. 12 months

7. An ACCF/AHA Guideline Class I recommendation is characterized as:

A. There is great deal of data supporting the use of a procedure/treatment B. The benefits of a procedure may or may not outweigh the risks C. The benefits of a procedure/treatment significantly outweigh the risks and generally should be performed/administered D. The procedure/treatment should be performed/administered even if there is increased risk in a specific patient (e.g., bleeding disorder, renal failure)

8. According to the 2011 ACCF/AHA/SCAI PCI Guidelines, which of the following statements best represents patients in whom platelet function testing may be considered?

A. Patients scheduled for elective PCI B. Patients at risk of poor clinical outcomes C. Patients enrolled in clinical trials D. Platelet function testing is not recommended until more data can be collected

9. Which of the following management strategies is most likely to be appropriate for a 56 year old male who presents with an NSTEMI with high risk features and, upon angiography, is found to have multi-vessel disease?

A. Medical management B. Percutaneous coronary intervention C. Coronary artery bypass graft

10. Prior to elective CABG surgery, a patient should preferably discontinue the use of clopidogrel for:

A. 24 hours B. 2 days C. 5 days D. 7 days

Maintenance is scheduled for 08/28/2024 6:00 AM EST - 08/28/2024 5:00 PM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following groups of patients experiences the greatest clinical benefit from treatment with prasugrel?

2. Which of the following medications is/are indicated for use in medically managed patients with ACS?

3. Patients with a prior history of stroke or TIA should not receive which of the following medications?

4. Which of the following medications is recommended to be used only with aspirin doses of 75-100 mg daily?

5. Which of the following statements regarding GP IIb/IIIa inhibitors is true?

6. The recommended optimal duration of dual anti-platelet therapy for a patient with a bare metal stent placed following non-ST elevation MI is:

7. An ACCF/AHA Guideline Class I recommendation is characterized as:

8. According to the 2011 ACCF/AHA/SCAI PCI Guidelines, which of the following statements best represents patients in whom platelet function testing may be considered?

9. Which of the following management strategies is most likely to be appropriate for a 56 year old male who presents with an NSTEMI with high risk features and, upon angiography, is found to have multi-vessel disease?

10. Prior to elective CABG surgery, a patient should preferably discontinue the use of clopidogrel for:

« Return to Activity

Maintenance is scheduled for 08/28/2024 6:00 AM EST - 08/28/2024 5:00 PM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following groups of patients experiences the greatest clinical benefit from treatment with prasugrel?

2. Which of the following medications is/are indicated for use in medically managed patients with ACS?

3. Patients with a prior history of stroke or TIA should not receive which of the following medications?

4. Which of the following medications is recommended to be used only with aspirin doses of 75-100 mg daily?

5. Which of the following statements regarding GP IIb/IIIa inhibitors is true?

6. The recommended optimal duration of dual anti-platelet therapy for a patient with a bare metal stent placed following non-ST elevation MI is:

7. An ACCF/AHA Guideline Class I recommendation is characterized as:

8. According to the 2011 ACCF/AHA/SCAI PCI Guidelines, which of the following statements best represents patients in whom platelet function testing may be considered?

9. Which of the following management strategies is most likely to be appropriate for a 56 year old male who presents with an NSTEMI with high risk features and, upon angiography, is found to have multi-vessel disease?

10. Prior to elective CABG surgery, a patient should preferably discontinue the use of clopidogrel for:

« Return to Activity

Customers who Purchased
this Activity also Purchased